Pharmaceutical

US DoD enlists VitriVax to develop one-shot vaccine for melioidosis

B. pseudomallei is resistant to many antibiotics and, without treatment, can be lethal to those infected.

Jul 19, 2023 - 20:00
US DoD enlists VitriVax to develop one-shot vaccine for melioidosis
B. pseudomallei is resistant to many antibiotics and, without treatment, can be lethal to those infected.
Read the original article

Tags:

Previous Article

Amarin restructures to counter downturn following Vascepa generics

Next Article

Santhera and Catalyst to market DMD drug vamorolone in North America

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

StromaForte by Swedish StromaBio for Osteoarthritis: Li...

Nov 6, 2023

Opinion: Clients bring politics into the therapy room. Here’s what that means for the therapist

Opinion: Clients bring politics into the therapy room. ...

Dec 9, 2023

U.S. life expectancy rose in 2022, but it remains below its pre-pandemic level

U.S. life expectancy rose in 2022, but it remains below...

Nov 29, 2023